|
|
Cholestech Corporation - Comparative Business Analysis Snapshot
Business Description
Cholestech Corporation. The Group's principal activity is to manufacture and market diagnostic products. It manufactures and markets the Cholestech LDX (R) and Cholestech GDX(TM) Systems that assist in assessing the risk of heart disease, diabetes and certain liver diseases outside hospitals and laboratories. It markets and distributes the GDX System under a global distribution agreement with Provalis Diagnostics Ltd. It markets the products and services in the United States, Europe, Asia and South America.
Competitor Analysis
This analysis compares Cholestech Corporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
